Abstract: The present application provides a lighting apparatus, including a lighting apparatus body and a control circuit built in the lighting apparatus body, where the lighting apparatus body includes a plurality of LED lamps; the control circuit includes a motor drive sub-circuit and an LED drive sub-circuit, and the LED drive sub-circuit is connected to the LED lamps, and configured to provide an LED drive signal for the LED lamps; and the motor drive sub-circuit is configured to be connected to a load motor outside the lighting apparatus body, so as to provide a motor drive signal for the load motor.

Abstract: An integrated nucleic acid loop-mediated isothermal amplification and mobile device system is provided and includes a main body and a power supply, where the 5 main body at least has a delivery unit, a heating unit and a control unit, the control unit is electrically connected to the delivery unit and the heating unit, and the power supply is electrically connected to the main body. A method for operating the integrated nucleic acid loop-mediated isothermal amplification and mobile device system is also provided.

Abstract: The present application provides a lighting apparatus, including a lighting apparatus body and a control circuit built in the lighting apparatus body, where the lighting apparatus body includes a plurality of LED lamps; the control circuit includes a motor drive sub-circuit and an LED drive sub-circuit, and the LED drive sub-circuit is connected to the LED lamps, and configured to provide an LED drive signal for the LED lamps; and the motor drive sub-circuit is configured to be connected to a load motor outside the lighting apparatus body, so as to provide a motor drive signal for the load motor.

Abstract: The present application relates to a method for computing illumination mixed lights. The method includes the following. Acquire a first chromaticity coordinate point corresponding to a first colored light, and acquire a second chromaticity coordinate point corresponding to a second colored light. Acquire a target chromaticity coordinate point, and compute a first lumen mixing ratio of the first colored light and the second colored light. Determine a middle chromaticity coordinate point corresponding to a middle-colored light obtained by mixing according to the first lumen mixing ratio. Determine a first compensation colored light and a second compensation colored light which are matched with the middle chromaticity coordinate point. Conduct compensation computation on the middle colored light, and determine a second lumen mixing ratio corresponding to the first compensation colored light, the second compensation colored light and the middle colored light when mixed to the target chromaticity coordinate point.

Abstract: The present application relates to a method for computing illumination mixed lights. The method includes the following. Acquire a first chromaticity coordinate point corresponding to a first colored light, and acquire a second chromaticity coordinate point corresponding to a second colored light. Acquire a target chromaticity coordinate point, and compute a first lumen mixing ratio of the first colored light and the second colored light. Determine a middle chromaticity coordinate point corresponding to a middle-colored light obtained by mixing according to the first lumen mixing ratio. Determine a first compensation colored light and a second compensation colored light which are matched with the middle chromaticity coordinate point. Conduct compensation computation on the middle colored light, and determine a second lumen mixing ratio corresponding to the first compensation colored light, the second compensation colored light and the middle colored light when mixed to the target chromaticity coordinate point.

Abstract: A cancer treatment method using a Ni-SOD mimic compound is provided, which includes administrating the Ni-SOD compound to a cancer cell of a cancer. The structure of the Ni-SOD mimic compound is represented as follows: wherein R1 represents H or A-R?; A represents a bond, O or N; L represents acetonitrile, water, or t-butyl isocyanate; R? represents H, unsubstituted or substituted alkyl, polyalkoxy, polydimethylsiloxane, polyurethane or other polymer materials or amino acid groups; R2 represents unsubstituted or substituted alkyl, alkoxy, siloxy, amino, alkylamine or hydrocarbyl groups; R3 represents unsubstituted or substituted amino, alkylamine, oxyalkylamine groups or magnetic nanoparticles attached oxyalkylamine. Ni is bivalent or trivalent.

Abstract: The present disclosure provides a compound for releasing nitric oxide; the compound has the structure of formula (I): The present disclosure also provides a pharmaceutical composition containing the compound of formula (I). The present disclosure further provides a method of releasing nitric oxide, the method includes: administrating the compound of formula (I). The present disclosure also provides a method of treating disease in a patient, the method includes administrating a therapeutically effective amount of the compound of formula (I). The present disclosure also provides the method for synthesizing the compound of formula (I).